• 24
    Apr

    AIFA Opens the Door: Patients Now Have a Seat at the HTA Table

    Italy's medicines agency AIFA has taken a significant step forward in how health technology assessment bodies [...]

    0 Comments

  • 14
    Apr

    The first JCA dossiers could arrive mid-2026; how will they impact market access?

    The Joint Clinical Assessment (JCA) framework represents a significant shift in how pharmaceutical products are evaluated [...]

    0 Comments

  • 8
    Jan
    Radicava oral suspension

    Shionogi’s Acquisition of Mitsubishi Tanabe Pharma’s Radicava Business

    Yesterday afternoon, I listened with interest to a presentation on Pharma’s Deal Review: M&A Dynamics Ahead [...]

    0 Comments